Upneeq vs. Lumify for droopy eyelid
Part of Eyes & vision clinical trials.
This study compares two eyedrop treatments—Upneeq and Lumify—to see which works better for acquired droopy eyelid (ptosis). It may help you if you have a droopy eyelid that makes it harder to see or affects your appearance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have droopy eyelid that developed over time (not from birth) and is at least 2.5 mm or more in one eye.
- You can attend two study visits that are at least 48 hours apart.
- You speak and understand English.
- You are willing and able to provide your consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
This study tests whether Lumify™ eye drops affect eye redness, eye pressure, and eyelid position in people with primary open-angle glaucoma. It may help doctors understand how “whitening” eye drops could interact with glaucoma treatment and symptoms.
This study tests a new treatment for Chinese patients whose droopy upper eyelid (acquired blepharoptosis) seriously affects their vision. It may help if your eyelid droops low enough to block part of your sight and you haven't had previous corrective surgery or certain eye conditions.
This trial compares two surgical methods (anterior vs posterior approach) for fixing a droopy upper eyelid (ptosis) that is caused by a stretched tendon. It will help determine which technique leads to better outcomes.
This study uses high-speed video to measure how the upper eyelid moves in children with droopy eyelids (ptosis). It may help doctors better understand eyelid function and improve treatment options.
This study compares a new non-surgical treatment called Ziplyft with traditional eyelid surgery (blepharoplasty) to reduce extra skin on the upper eyelids. It may be a good option for people who want to refresh their eyes without a full surgery.
Hear when a new Acquired Ptosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.